SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers

F Rovida, I Cassaniti, S Paolucci, E Percivalle… - Nature …, 2021 - nature.com
Vaccine breakthrough SARS-CoV-2 infection has been monitored in 3720 healthcare
workers receiving 2 doses of BNT162b2. SARS-CoV-2 infection is detected in 33 subjects …

Breakthrough infections in BNT162b2-vaccinated health care workers

B Lange, M Gerigk, T Tenenbaum - New England Journal of …, 2021 - Mass Medical Soc
Breakthrough SARS-CoV-2 Infections in Health Care Workers In a German study, 4 health
care workers out of 1137 (0.35%) who had received one of the mRNA SARS-CoV-2 …

Covid-19 breakthrough infections in vaccinated health care workers

M Bergwerk, T Gonen, Y Lustig, S Amit… - … England Journal of …, 2021 - Mass Medical Soc
Background Despite the high efficacy of the BNT162b2 messenger RNA vaccine against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare breakthrough …

Transmission of SARS-CoV-2 variant B. 1.1. 7 among vaccinated health care workers

P Ioannou, S Karakonstantis, E Astrinaki… - Infectious …, 2021 - Taylor & Francis
Background Vaccination against COVID-19 is among the most effective measures to stop
the spread of the disease. However, acceptance of vaccination against COVID-19 among …

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel: A …

SR Singer, FJ Angulo, DL Swerdlow… - …, 2021 - thelancet.com
Abstract Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of
Concern (VoC) after becoming the dominant strain in South Africa and spreading …

Vaccine breakthrough infections with SARS-CoV-2 variants

E Hacisuleyman, C Hale, Y Saito… - … England Journal of …, 2021 - Mass Medical Soc
Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of
clinical concern. In a cohort of 417 persons who had received the second dose of BNT162b2 …

Differences in SARS-CoV-2-specific antibody responses after the first, second, and third doses of BNT162b2 in naïve and previously infected individuals: a 1-year …

M Ogrič, P Žigon, E Podovšovnik, K Lakota… - Frontiers in …, 2022 - frontiersin.org
Background Safe and effective vaccines against COVID-19 are critical for preventing the
spread of SARS-CoV-2, but little is known about the humoral immune response more than 9 …

[HTML][HTML] BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B. 1.1. 7 in high-risk populations in Israel

A Munitz, M Yechezkel, Y Dickstein, D Yamin… - Cell Reports …, 2021 - cell.com
Since the emergence of the SARS-CoV-2 pandemic, various genetic variants have been
described. The B. 1.1. 7 variant, which emerged in England during December 2020, is …

Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel

MJ Cohen, Y Oster, AE Moses, A Spitzer… - JAMA Network …, 2022 - jamanetwork.com
Importance Despite the high 3-dose vaccination rate among health care workers (HCWs) in
Israel, a high rate of SARS-CoV-2 breakthrough infections in this group was observed during …

Asymptomatic and symptomatic SARS-CoV-2 infections after BNT162b2 vaccination in a routinely screened workforce

L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - Jama, 2021 - jamanetwork.com
Methods| In March 2020, St Jude Children's Research Hospital initiated routine, test-based
screening of asymptomatic workers and targeted testing for symptomatic individuals and …